Niagen Bioscience (NAGE) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known ...
Niagen Bioscience (NAGE) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago. These ...
Ladies and gentlemen, thank you for standing by, and welcome to the Niagen Biosciences, Inc. Third Quarter of 2025 Earnings Conference Call. My name is Tamika, and I will be your conference operator ...
In a fiery speech in Muzaffarpur, Prime Minister Narendra Modi launched a blistering attack on the Congress and RJD, accusing them of disrespecting Bihar's culture. 'For them, the worship of Chhathi ...
External Affairs Minister S Jaishankar criticized the UN for its failure to act decisively against terrorism, citing the Pahalgam attack as an example of its undermined credibility due to political ...
Guwahati: For the first time in Assam, a unique book fair offering free books to students and readers to spark a reading revolution will be held in Lakhimpur district in Dec. This initiative aims to ...
Investing.com - Niagen Bioscience (NASDAQ: NAGE) reported third quarter EPS of $0.050, $0.03 better than the analyst estimate of... ByInvesting.com • Nov 04, 2025 Niagen Bioscience stock maintains Buy ...
Niagen Bioscience (NAGE) exceeded Q3 2025 forecasts with EPS of $0.05 vs $0.02 expected and revenue of $34M vs $30.83M expected, despite stock dipping 3.73% after hours. Revenue grew 33% ...
JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...
JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results